Another important biological function for the aryl hydrocarbon receptor.
暂无分享,去创建一个
[1] O. Fiehn,et al. Activation of Aryl Hydrocarbon Receptor Induces Vascular Inflammation and Promotes Atherosclerosis in Apolipoprotein E−/− Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[2] H. Weiner,et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis , 2010, Proceedings of the National Academy of Sciences.
[3] Xiaoqing Chang,et al. The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. , 2008, Molecular biology of the cell.
[4] J. Buer,et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.
[5] D. Seldin,et al. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. , 2007, Cancer research.
[6] F. Matsumura,et al. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. , 2007, Molecular endocrinology.
[7] H. Swanson,et al. Lack of the Aryl Hydrocarbon Receptor Leads to Impaired Activation of AKT/Protein Kinase B and Enhanced Sensitivity to Apoptosis Induced via the Intrinsic Pathway , 2007, Journal of Pharmacology and Experimental Therapeutics.
[8] J. Reiners,et al. Aryl Hydrocarbon Receptor Modulation of Tumor Necrosis Factor-α-induced Apoptosis and Lysosomal Disruption in a Hepatoma Model That Is Caspase-8-independent* , 2006, Journal of Biological Chemistry.
[9] G. Sonenshein,et al. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB. , 2006, Cancer research.
[10] A. Akintobi,et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. , 2006, Toxicology and applied pharmacology.
[11] N. Kerkvliet,et al. Cutting Edge: Activation of the Aryl Hydrocarbon Receptor by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Generates a Population of CD4+CD25+ Cells with Characteristics of Regulatory T Cells1 , 2005, The Journal of Immunology.
[12] P. A. Pérez-Mancera,et al. Immortalized Mouse Mammary Fibroblasts Lacking Dioxin Receptor Have Impaired Tumorigenicity in a Subcutaneous Mouse Xenograft Model* , 2005, Journal of Biological Chemistry.
[13] H. Swanson,et al. Dioxin-induced Immortalization of Normal Human Keratinocytes and Silencing of p53 and p16INK4a* , 2004, Journal of Biological Chemistry.
[14] F. Bibeau,et al. Roles of the Transcription Factors Snail and Slug During Mammary Morphogenesis and Breast Carcinoma Progression , 2004, Journal of Mammary Gland Biology and Neoplasia.
[15] Stephen Safe,et al. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. , 2003, Molecular pharmacology.
[16] Matthew W. Strobeck,et al. Role of the aryl hydrocarbon receptor in cell cycle regulation. , 2002, Toxicology.
[17] M. Nagarkatti,et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells , 2002, Archives of Toxicology.
[18] S. Korsmeyer,et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals , 2001, Nature Genetics.
[19] A. Fornace,et al. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. , 2000, Molecular pharmacology.
[20] M. E. Hahn. The aryl hydrocarbon receptor: a comparative perspective. , 1998, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.
[21] J. Whitlock,et al. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin , 1996, Molecular and cellular biology.
[22] G. Perdew,et al. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. , 1994, The Journal of biological chemistry.
[23] D. Nebert,et al. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. , 1991, Pharmacogenetics.
[24] O. Hankinson. Dominant and recessive aryl hydrocarbon hydroxylase-deficient mutants of mouse hepatoma line, Hepa-1, and assignment of recessive mutants to three complementation groups , 1983, Somatic cell genetics.
[25] D. Nebert,et al. Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically "nonresponsive" to other aromatic hydrocarbons. , 1974, The Journal of biological chemistry.
[26] Nebert Dw,et al. Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse. , 1972 .
[27] F. Matsumura,et al. Activation of inflammatory mediators and potential role of Ah-receptor ligands in foam cell formation , 2007, Cardiovascular Toxicology.
[28] W. Foster,et al. Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output , 2005, Clinical & Experimental Metastasis.
[29] C. Bradfield,et al. Purification and N-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse. , 1991, Molecular pharmacology.
[30] D. Nebert,et al. Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse. , 1972, Federation proceedings.